CFMSX
Price
$12.98
Change
+$0.01 (+0.08%)
Updated
Jul 31 closing price
Net Assets
3.25B
VIMSX
Price
$88.38
Change
-$0.07 (-0.08%)
Updated
Jul 31 closing price
Net Assets
223.97B
Interact to see
Advertisement

CFMSX vs VIMSX

CFMSX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 224B vs. CFMSX (3.25B). VIMSX pays higher dividends than CFMSX: VIMSX (1.20) vs CFMSX (0.74). CFMSX was incepted earlier than VIMSX: CFMSX (3 years) vs VIMSX (28 years). CFMSX (0.82) is less costly to investors than VIMSX (0.17). CFMSX is a more actively managed with annual turnover of: 26.00 vs. VIMSX (16.00). CFMSX has a lower initial minimum investment than VIMSX: CFMSX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 13.46 vs. CFMSX (12.70).
CFMSXVIMSXCFMSX / VIMSX
Total Expense Ratio0.520.17306%
Annual Report Gross Expense Ratio0.820.17482%
Fund Existence3 years28 years-
Gain YTD10.28011.62588%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.25B224B1%
Annual Yield % from dividends0.741.2062%
Returns for 1 year12.7013.4694%
Returns for 3 yearsN/A43.32-
Returns for 5 yearsN/A35.82-
Returns for 10 yearsN/A158.99-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BROS65.830.40
+0.61%
Dutch Bros
IMMP0.38N/A
+0.58%
Immutep Limited
BPOPM25.11N/A
N/A
Popular
GIW10.11-0.01
-0.10%
GIGCAPITAL8 CORP
URGN38.24-2.85
-6.94%
UroGen Pharma Ltd